The global Biodegradable Stent market was valued at approximately USD 2.1 billion in 2024 and is projected to grow at a CAGR of 9.6% from 2025 to 2032. Rising cardiovascular disease prevalence, which accounts for nearly 32% of global deaths annually, is accelerating demand. In 2023 alone, over 18.6 million deaths were linked to heart-related conditions, pushing healthcare systems to adopt advanced stent technologies.
Strong Year-over-Year Growth Driven by Cardiac Cases
The Biodegradable Stent market recorded a 7.8% year-over-year growth from 2022 to 2023, increasing from USD 1.75 billion to USD 1.89 billion. In 2024, the market further expanded by 11.1%, reaching USD 2.1 billion. This surge is largely attributed to a 12% rise in angioplasty procedures globally, crossing 4.5 million procedures annually.
Between 2021 and 2024, hospital adoption rates of biodegradable stents increased from 18% to 27%, reflecting a 50% relative growth. Additionally, reimbursement coverage for biodegradable stents improved by 22% across developed economies, further boosting utilization rates.
Historical Data Highlights Consistent Expansion (2016–2024)
The Biodegradable Stent market has demonstrated consistent expansion over the past decade. In 2016, the market stood at USD 0.95 billion, growing to USD 1.1 billion in 2017 and USD 1.28 billion in 2018, marking an average annual growth rate of 10.2%.
From 2019 to 2021, growth slightly slowed due to regulatory challenges and pandemic disruptions, with values recorded at USD 1.42 billion (2019), USD 1.39 billion (2020), and USD 1.58 billion (2021). However, post-2021 recovery accelerated growth by over 15% in two years, indicating strong market resilience.
Market Drivers Backed by Quantitative Insights
Cardiovascular disease incidence is increasing at approximately 3.5% annually worldwide. In emerging economies, the rate is even higher at 5.2%, significantly boosting demand for minimally invasive procedures. Biodegradable stents reduce long-term complications by nearly 35% compared to traditional metallic stents.
Clinical studies indicate a 28% reduction in late-stage thrombosis and a 40% improvement in arterial healing with biodegradable stents. These performance benefits are driving a 14% annual increase in physician preference toward biodegradable solutions.
Regional Breakdown Shows Asia-Pacific Leading Growth
North America accounted for 38% of the global Biodegradable Stent market in 2024, valued at USD 0.8 billion. Europe followed with a 29% share, reaching USD 0.61 billion. However, Asia-Pacific is the fastest-growing region, expanding at a CAGR of 11.8%.
China and India collectively contributed over USD 0.42 billion in 2024, with procedural volumes increasing by 18% year-over-year. Government healthcare spending in Asia-Pacific rose by 9.3% in 2023, with cardiovascular care receiving approximately 21% of total allocations.
Production Volume and Technological Advancements
Global production of biodegradable stents reached approximately 6.8 million units in 2024, up from 5.9 million units in 2023, reflecting a 15.2% increase. Advanced polymer-based stents accounted for 62% of total production, while magnesium-based variants contributed 28%.
R&D investments in biodegradable stent technology increased by 19% in 2024, surpassing USD 520 million globally. Innovations in bioresorbable materials have improved stent degradation timelines by 25%, enhancing patient outcomes.
Industry and Company-Level Statistics
Top medical device manufacturers collectively held around 64% of the global Biodegradable Stent market share in 2024. The top five companies generated over USD 1.3 billion in combined revenue from biodegradable stent sales.
Clinical trial activity also surged, with over 120 ongoing trials in 2024 compared to 85 in 2021, marking a 41% increase. Approval rates improved by 18% year-over-year due to streamlined regulatory frameworks in key markets.
Government Initiatives and Investment Trends
Global healthcare expenditure crossed USD 9.8 trillion in 2024, with approximately 7.5% allocated to cardiovascular treatments. Governments in developed regions increased funding for cardiac innovation by 14%, while emerging markets saw a 21% rise in public healthcare investments.
In India, cardiovascular health programs received over USD 1.2 billion in funding in 2023, marking a 26% increase compared to 2020. Similarly, the U.S. allocated nearly USD 4.5 billion toward cardiac device innovation, up by 11% year-over-year.
Future Projections and Market Forecast (2025–2032)
The Biodegradable Stent market is expected to reach USD 2.32 billion in 2025 and USD 3.1 billion by 2028. By 2032, the market is projected to hit USD 4.8 billion, driven by increasing adoption rates and technological advancements.
Procedure volumes are expected to grow at a CAGR of 6.7%, surpassing 7.8 million annually by 2030. Adoption rates of biodegradable stents are projected to rise from 27% in 2024 to 45% by 2032, reflecting a 66% increase.
Asia-Pacific is forecasted to contribute nearly 36% of global growth during this period, while North America will maintain a steady CAGR of 8.2%. Europe is expected to grow at 7.5%, supported by favorable reimbursement policies.
Market Challenges Quantified
Despite strong growth, cost remains a barrier, with biodegradable stents priced 18–25% higher than traditional alternatives. Limited long-term clinical data has slowed adoption in some regions, with only 62% of cardiologists expressing full confidence in current solutions.
However, ongoing clinical trials and increased data availability are expected to improve confidence levels to over 80% by 2028.
Conclusion: Data-Driven Outlook Indicates Robust Expansion
The Biodegradable Stent market is on a strong upward trajectory, growing from USD 2.1 billion in 2024 to an anticipated USD 4.8 billion by 2032 at a CAGR of 9.6%. With cardiovascular disease rates rising by over 3.5% annually and procedural volumes exceeding 4.5 million, demand will remain strong.
Technological advancements, increasing healthcare investments, and a projected 66% rise in adoption rates will further accelerate market growth. Asia-Pacific’s 11.8% CAGR and expanding production volumes reinforce a positive long-term outlook for the Biodegradable Stent market.
Read Full Research Study: https://marketintelo.com/report/biodegradable-stent-market